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Occludin Independently Regulates Permeability under
Hydrostatic Pressure and Cell Division in Retinal
Pigment Epithelial Cells
Brett E. Phillips,1 Limary Cancel,2 John M. Tarbell,2 and David A. Antonetti1,3
PURPOSE. The aim of this study was to determine the function
of the tight junction protein occludin in the control of perme-
ability, under diffusive and hydrostatic pressures, and its con-
tribution to the control of cell division in retinal pigment
epithelium.
METHODS. Occludin expression was inhibited in the human
retinal pigment epithelial cell line ARPE-19 by siRNA. Deple-
tion of occludin was confirmed by Western blot, confocal
microscopy, and RT-PCR. Paracellular permeability of cell
monolayers to fluorescently labeled 70 kDa dextran, 10 kDa
dextran, and 467 Da tetramethylrhodamine (TAMRA) was
examined under diffusive conditions or after the application of
10 cm H2O transmural pressure. Cell division rates were de-
termined by tritiated thymidine incorporation and Ki67 immu-
noreactivity. Cell cycle inhibitors were used to determine
whether changes in cell division affected permeability.
RESULTS. Occludin depletion increased diffusive paracellular
permeability to 467 Da TAMRA by 15%, and permeability under
hydrostatic pressure was increased 50% compared with con-
trol. Conversely, depletion of occludin protein with siRNA did
not alter diffusive permeability to 70 kDa and 10 kDa RITC-
dextran, and permeability to 70 kDa dextran was twofold
lower in occludin-depleted cells under hydrostatic pressure
conditions. Occludin depletion also increased thymidine incor-
poration by 90% and Ki67-positive cells by 50%. Finally, cell
cycle inhibitors did not alter the effect of occludin siRNA on
paracellular permeability.
CONCLUSIONS. The data suggest that occludin regulates tight
junction permeability in response to changes in hydrostatic
pressure. Furthermore, these data suggest that occludin also
contributes to the control of cell division, demonstrating a
novel function for this tight junction protein. (Invest Ophthal-
mol Vis Sci. 2008;49:2568–2576) DOI:10.1167/iovs.07-1204
The blood-retinal barrier is composed of epithelial cells ofthe retinal pigment epithelium and endothelial cells of the
retinal vasculature that are under transmural hydrostatic pres-
sure gradients and are composed of cells with a very low
mitotic index with well-developed tight junctions. Tight junc-
tions establish physiological barriers that regulate the move-
ment of ions, small solutes, and fluid between tissue compart-
ments.1,2 The retinal pigment epithelium contributes to the
outer portion of the blood retinal barrier,3,4 and the retinal
pigment epithelial (RPE) dysfunction caused by tight junction
opening and increased permeability results in macular edema
associated with retinitis pigmentosa.5–8
Transmembrane proteins that contribute to tight junction
barrier properties include claudins, tricellulin, and occlu-
din.9–12 Occludin is a tetraspan transmembrane protein lo-
cated at tight junctions but its precise cellular functions remain
unclear. Changes in occludin content correlate with altered
permeability, making occludin a likely regulator of overall
paracellular permeability of the tight junction.13–16 Similarly,
the loss of occludin protein is associated with a number of
abnormalities such as diabetic retinopathy14 and inflammatory
bowel disease.17 Treatment of RPE cells with hepatocyte
growth factor18 or interleukin-119 reduced occludin content
associated with increased permeability. Furthermore, treat-
ment of ARPE19 cells with matrix metalloproteinases 2 and 9,
two proteinases elevated in the retina in diabetes, specifically
decreased occludin content and increased permeability.20
These studies demonstrate that cytokines and proteinases that
are altered in a number of retinal diseases, including diabetic
retinopathy, reduce occludin content associated with in-
creased permeability.
The contribution of occludin to barrier properties remains
controversial. Blocking the extracellular loops21–25 and reduc-
ing the protein content26 of occludin alter paracellular perme-
ability in a number of cell systems. Occludin-deficient mice are
viable; tight junction ultrastructure appears unaltered, and iso-
lated intestinal tissues demonstrate normal transepithelial re-
sistance (TER) and permeability to mannitol. These mice do,
however, display a number of aberrant phenotypes in tissues
containing tight junctions, including testicular atrophy in
males, inability to suckle in females, gastric mucus cell hyper-
plasia, and calcification of the brain.27,28 Additional evidence
for occludin in regulating epithelial cell division has been
suggested by the ability of exogenous occludin expression to
revert the phenotype of raf-transformed rat salivary gland epi-
thelial cells.29
Most occludin permeability studies are performed at or near
atmospheric pressure, and the role of occludin has yet to be
assessed under a transmural pressure gradient that more
closely models physiological conditions. The net movement of
water across tissue barriers is governed by differential fluid and
oncotic pressure, as expressed in Starling’s equations and sub-
sequent adaptations (for a review, see Salathe30). Application
of a transmural hydrostatic pressure gradient across endothelial
cell monolayers rapidly increases effective permeability of sol-
utes through convective forces. However, during the 30 to 60
minutes after pressurization, the endothelial cells respond by
reducing effective solute and water permeability.31–33 This
sealing effect34 is an adaptive biological response to changes in
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hydrostatic pressure.33 In the present study, the contribution
of occludin to regulation of the blood-retinal barrier after ap-
plication of hydrostatic pressure was examined using the RPE
cell line ARPE-19. This cell line has well-developed tight junc-
tions in stable monolayers.3,4 In addition, these studies ad-
dressed the novel hypothesis, suggested by occludin knockout
mice, that occludin may contribute to growth control, and they
examined the relationship of growth control to permeability
under diffusive conditions.
MATERIALS AND METHODS
Cell Culture and Electroporation
ARPE-19 cells (ATCC, Manassas, VA) were grown in DMEM/F-12 Ham
media with L-glutamine and 15 mM HEPES (Sigma, St. Louis, MO) and
were supplemented with 1.16 g/L sodium bicarbonate, 10% FBS, and
antibiotic-antimycotic (Gibco BRL, Rockville, MD). The introduction of
siRNA was achieved using 5.0  105 cells in an electroporator (Nucleo-
fector II, program number L-23 [Amaxa, Cologne, Germany] with
Nucleofector Kit V). Each reaction received 10 pmol human silencer
negative control siRNA 1 or occludin siRNA 143665 (Ambion, Austin,
TX). Transfection efficiency was tested using plasmid for enhanced
green fluorescence protein and a fluorescence-labeled small RNA oli-
gonucleotide; in both cases, it was near 100% with repeat experiments.
Unless stated otherwise, cells were plated on six-well Costar (Cam-
bridge, MA) tissue culture plates at a density of 5.0  105 cells/well and
were harvested 4 days after electroporation. Confluence of the
ARPE-19 cell monolayer was confirmed by observation with a phase-
contrast microscope 1 day after plating. Three days after plating, cells
were washed twice with phosphate-buffered saline (PBS) and were fed
with serum-free media. All cell assays were on day 4 after electropo-
ration. To inhibit the cell cycle, cells were treated with DMSO con-
taining 5 M aphidicolin (Calbiochem, San Diego, CA), or 10 M
roscovitine (Calbiochem) for 4 hours.
Protein Quantification
Relative protein content was quantified by Western immunoblotting.
Cells were harvested in a detergent-based extraction buffer, and total
protein concentrations were determined as previously described.35
The Western gel system (NuPAGE; Invitrogen, Carlsbad, CA) was used
to separate proteins. Forty micrograms protein was diluted in LDS
sample buffer (NuPAGE, Invitrogen) and was loaded on 4% to 12%
Bis-Tris 1.5-mm, 10-well gels (NuPAGE, Invitrogen). The gels were run
according to NuPAGE protocols using MOPS SDS running buffer (In-
vitrogen). The gels were then transferred to MSI nitrocellulose (Fisher
Scientific, Pittsburgh, PA), blocked in 5% fat-free milk in TBST, and
immunoblotted with polyclonal rabbit ZO-1 (N-term; 1:150), poly-
clonal rabbit Claudin-1 (1:150; Invitrogen), or monoclonal mouse oc-
cludin (1:1000; BD Biosciences, San Jose, CA). Primary antibodies were
detected with alkaline phosphatase-conjugated anti-mouse IgG and
chemifluorescence or horseradish peroxidase-conjugated anti-rabbit
IgG and chemiluminescence (ECL Plus; GE Healthcare, Buckingham-
shire, England). Results were analyzed using acquisition software (Im-
ageQuant 5.2 [Molecular Dynamics, Sunnyvale, CA] or Genesnap [Syn-
Gene, Frederick, MD]) software.
RNA and DNA Quantification
RNA was quantified using real-time PCR. RNA was collected using an
RNA isolation kit (ToTALLY RNA Kit; Ambion, Austin, TX). RNA integ-
rity and concentration were determined using a bioanalyzer (Agilent
2100; Agilent Technologies, Santa Clara, CA). cDNA was made from
1 g total RNA with oligo-DT primers using a system for the
synthesis of high-quality first-strand cDNA (Super Script III First-
Strand Synthesis Systems for RT-PCR; Invitrogen). To quantify
mRNA content, reactions containing 200 ng cDNA in a total volume
of 10 L were assessed with gene expression assay (TaqMan; Ap-
plied Biosystems, Foster City, CA) in combination with a PCR
system (7900HT Fast Real-Time PCR System; Applied Biosystems).
Gene expression primer sets used were as follows: occludin
Hs00170162_m1, claudin-1 Hs00221623_m1, claudin-2 Hs00252666_s1,
ZO-1 Hs00268480_m1, E-cadherin Hs00170423_m1, and cyclophilin A
Hs99999904_m1 (Applied Biosystems). Cyclophilin A was used as an
endogenous housekeeping gene for normalization between samples.
Relative mRNA content was determined using the Ct method in the
SDS 2.2 software (Applied Biosystems).36
DNA content was measured using an assay kit protocol (Quant-iT
Pico Green dsDNA Assay; Invitrogen). Cells were plated on 13-mm
diameter, 24-well tissue culture plates at a density of 1.0  105 cells/
well. On day 4, media were collected, and cell lysates were collected
as described. Standard curves incorporated either media or lysis buffer
as appropriate.
Immunocytochemistry
Cells were plated on 12-mm diameter glass coverslips (Fisher Scien-
tific) at a density of 1.5  105 cells/well. At day 4 after electroporation,
cells were fixed in 1% paraformaldehyde for 10 minutes as previously
described.35 Coverslips were incubated in PBS, 10% goat serum, and
0.1% Triton X-100 with rat anti-ZO-1 mAb culture supernatant (1:4),
rabbit anti-Ki67 (1:1000; Visionbiosystems, Norwell, MA), and mono-
clonal mouse occludin IgG (1:200; Invitrogen) for 3 days. Detection of
primary antibodies was with Alexa 488 anti-mouse, Alexa 555 anti-
rabbit, and Alexa 647 anti-rat antibodies (Invitrogen), and DNA was
detected with Hoechst stain (1:1000) for 1 hour. Cells were imaged on
a confocal microscope (TCS SP2 AOBS; Leica; Wetzlar, Germany). Cell
density was calculated by dividing the total cell number by the field
surface area (0.1406 mm2). The percentage of Ki67-positive cells was
calculated by dividing Ki67-positive cells by total Hoechst-stained cells
in a given field. Nine total fields were counted per condition across
three coverslips.
Diffusive RPE Permeability and
TER Measurements
Cells were plated on 12-mm diameter, 0.4-m pore size, polyester
transwell filters (Costar) at 1.0  105 cells/well. TERs were measured
using an EVOM with a STX2 Electrode (World Precision Instruments,
Sarasota, FL) on day 4 before solute permeability experiments. Dextran
diffusive permeability rates were determined by placing 10 M of 70
kDa (Sigma) or 10 kDa (Invitrogen) RITC-dextran in the apical trans-
well chamber. Every 30 minutes, 50-L aliquots were collected from
the basolateral chamber for 3.5 hours. At the final time point, a 50-L
aliquot was collected from the apical chamber. Fluorescence aliquots
were quantified (FluorImager 595; Molecular Dynamics), and diffusive
permeability rates (Po) in centimeters per second were calculated as
previously described.35
Measurement of 467-Da TAMRA permeability required quantifica-
tion of the changing apical TAMRA concentration over the course of
the experiment. Aliquots were collected every 15 minutes from the
basolateral chamber and every 30 minutes from the apical chamber for
2 hours. Apical chamber concentrations were fit to a linear regression,
and the time-averaged apical fluorescence across each 15-minute inter-
val was used to calculate the Po as follows:
Po  FA/tVA/FLtA (1)
where Po is diffusive permeability (cm/s), FA is the change in baso-
lateral fluorescence, FLt is apical fluorescence at 15-minute intervals, t
is the change in time (15-minute intervals), VA is basolateral chamber
volume (cm3), and A is filter surface area (cm2).
RPE Permeability Measurements under
Transmural Pressure
Measurement of 70-kDa RITC dextran and 467-Da TAMRA permeability
across RPE cell monolayers under 10 cm H2O pressure was achieved
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using a sealed chamber coupled to a fiber-optic light detection system,
as previously described with subsequent modifications.33 Briefly, a
fiber-optic lead directs 532-nm light provided by a 10 mW crystal laser
to the basolateral chamber below the transwell filter. A second fiber-
optic lead carries light from the basolateral chamber to a photon-
counting detector (C&L Instruments, Hummelstown, PA) after passage
through a 571-nm high-pass filter for real-time measurement of fluores-
cent solute permeability across the cell monolayer. The basolateral
chamber connects to hydraulic tubing, allowing for a pressure differ-
ential to be applied across the cell monolayer. The system accommo-
dates eight chambers to simultaneously measure solute permeability.
Cell monolayers were placed in the chambers for 1 hour without
pressure for equilibration before the application of pressure, serum-
free media were used as described with the addition of 1% BSA, and 10
cm H2O pressure was applied for 2 hours. For permeability measure-
ments, the apical media chamber received 1.44 M of 70-kDa RITC-
dextran or 480 nM TAMRA. Initial fluorophore concentrations were
selected to produce fluorescence readings within the photon-counting
detector range. RITC-dextran (70 kDa) was added to the apical cham-
ber at the beginning of equilibration before pressure application.
TAMRA was added to the apical chamber 1 hour after pressure appli-
cation because the apical TAMRA concentration was depleted too
quickly to apply TAMRA earlier. Fluorescence intensity measurements
for the basolateral chamber were smoothed using the supsmooth
function from Mathcad 13 (Cambridge, MA), converted to nM concen-
trations based on standard curves generated for each cell chamber, and
averaged into 5-minute intervals. Effective permeability rates (Pe) were
calculated in cm/s units, as previously described.37 Statistical analysis
(Prism 4.02 software; GraphPad Software, San Diego, CA) was con-
ducted using both ANOVA and area under the curve (AUC) analyses
with baseline set at 0 and two-tailed t-test.
Cell Viability and DNA Synthesis Measurements
To measure DNA synthesis, cells were plated on 13-mm diameter,
24-well tissue culture plates at a density of 1.0  105 cells/well. On day
4 after electroporation, monolayers with 2 Ci tritiated thymidine
added to 500 L media in each well were incubated for 2 hours at
37°C. The cells were then washed with PBS, and the nucleic acid was
precipitated with 300 L of 10% trichloric acid (TCA) for 10 minutes
at 25°C. The TCA was aspirated, and the precipitates were solubilized
in 0.2 M NaOH with 40 g/mL DNA type I for 30 minutes at 37°C. The
solution was transferred to a scintillation counter, and disintegrations
per minute was read for 1 minute (LS 6000SC; Beckman Coulter,
Fullerton, CA). Relative thymidine incorporation after background sub-
traction was analyzed by t-test. Cells were assayed (Live/Dead Viability/
Cytotoxicity Kit for Animal Cells; Invitrogen) according to the supplied
protocol. For positive control of cell death, cells were treated with 70%
ethanol for 30 minutes.
Cell viability was also assessed using fluorescence-activated cell
sorting. Cells were lightly trypsinized in a 0.5 trypsin solution until
the cells lifted off the plate. A detection kit (Annexin V-PE Apoptosis
Detection Kit I; BD Biosciences) was used to label the cells according
to the manufacturer’s protocol and were read on a FACScan (BD
Biosciences). Standard quadrant analysis was performed, and all cells
stained for Annexin V-PE and 7-AAD were pooled to represent the
number of dead cells.
Electron Microscopy
Cells were plated on 24-mm diameter, 0.4-m pore size, polyester
transwell filters (Costar) at 5.0  105 cells/well. Cells were pressurized
to 10 cm H2O for 2 hours before fixation. The apical media chamber
contained 2 mL media. To the apical chamber, 4 mL of 4% paraformal-
dehyde, 1% glutaraldehyde (Electron Microscopy Science, Hatfield,
PA), and 0.1 M sodium cacodylate buffer (Fisher Scientific) was added.
Cells were fixed in this solution for 1 hour under pressure along with
nonpressurized transwell filters in six-well tissue culture plates. After 1
hour of fixation, the pressure was removed, and all filters were washed
in 0.1 M sodium cacodylate. Undiluted fixative was then applied to all
filters for an additional 20 minutes. Cells were washed with 0.1 M
sodium cacodylate and postfixed with a 1% osmium and 1.5% potas-
sium ferrocyanide solution in 0.1 M sodium cacodylate overnight. The
cells were then dehydrated with progressively increasing concentra-
tions of ethanol and imbedded in resin (Epon 812; Electron Microscopy
Science). Sections were viewed and imaged under an electron micro-
scope (model 400; Philips, Eindhoven, Netherlands). The presence or
absence of pressure did not affect tight junction appearance in images
(data not shown); therefore, only pressurized images are presented.
Statistical Analysis
Unless otherwise noted, statistical analysis was performed as follows.
Within a data set, samples greater than 2 SD were discarded. A two-
tailed t-test (two conditions) or ANOVA (three or more conditions) was
performed using software for statistical analysis (InStat 3.05; Graph-
Pad). P  0.05, P  0.01, and P  0.001 were considered significant,
as indicated in the figures and legends.
RESULTS
Tight Junction Protein Content
after Occludin Depletion
ARPE-19 cells were transfected with occludin-targeted siRNA
or a human negative control siRNA that did not match any
sequence in the human genome. Four days after siRNA trans-
fection, mRNA and protein content were examined. Occludin-
targeted siRNA reduced occludin mRNA by 65% compared
with control siRNA with no significant changes in mRNA of
tight and adherens junction proteins ZO-1, claudin-1, claudin-2,
or E-cadherin (Fig. 1A). Protein levels were quantified by West-
ern blot analysis. Occludin protein content similarly decreased
by 60% with occludin-targeted siRNA treatment with no
change in ZO-1 or claudin-1 protein content (Fig. 1B). In
preliminary experiments, ARPE-19 cells were compared with
mock-transfected cells, scrambled siRNA for occludin, and oc-
cludin siRNA conditions. In these experiments, occludin re-
duction of 50% to 60% was observed in the occludin siRNA
alone, not in any other conditions. Immunocytochemistry re-
vealed that localization of ZO-1 at the plasma membrane did
not change with reduced occludin content (Fig. 2A). Transmis-
sion electron micrographs of osmium tetroxide-stained
ARPE19 cells, ARPE19 cells with control scramble RNA, or
ARPE19 cells with occludin siRNA demonstrated tight junc-
tions that appeared morphologically identical at the ultrastruc-
tural level (Fig. 2B). These data demonstrate the specificity of
the siRNA and are consistent with the formation of tight junc-
tions in occludin-deficient mice27,28 and tissue culture stud-
ies.26
Permeability under Hydrostatic Pressure
after Occludin Depletion
The effect of occludin depletion on permeability was tested
under an atmospheric and a physiological transmural pressure
gradient. Diffusive permeability of ARPE-19 cell monolayers
was tested with a range of solute sizes after transfection with
siRNA to occludin. Under diffusive conditions, occludin siRNA
did not affect permeability to 70 kDa or 10 kDa RITC-dextran,
whereas permeability to 467 Da TAMRA increased 15% (Fig.
3A). Cell monolayer TER was tested and declined 20% with
occludin protein reduction (Fig. 3B). Thus, in the absence of a
pressure gradient, the reduction of occludin content only in-
creased diffusive permeability to 467 Da TAMRA.
Although the role of occludin in permeability has been
previously examined under diffusive conditions, the contribu-
tion of occludin to the cell’s response to a pressure differential
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has yet to be examined. Although the pressure differential
across the RPE is unknown, normal intraocular pressure ranges
from 10 to 20 mm Hg. Permeability of ARPE-19 monolayers was
tested under 10 cm H2O pressure (7.35 mm Hg) after siRNA
transfection. Previous studies have demonstrated fluid flow
across the RPE from the retina to the choroid,38,39 which is
well vascularized and has vessels with low barrier properties.
Therefore, the pressure used was slightly less than a normal
pressure differential across the RPE assuming a negligible neg-
ative pressure from the choroidal side. Pressure application to
cell monolayers initially results in a fourfold to sevenfold ele-
vation of permeability to 70 kDa RITC-dextran, but the cells
responded to the elevated pressure and reduced permeability
over the next 60 minutes (Fig. 4A). This is the first demonstra-
tion that RPE cells, like endothelial cells,33 display an adaptive
response or a sealing effect to transmural pressure. Permeabil-
ity after 60 minutes was analyzed statistically with ANOVA and
AUC analysis. ARPE-19 cells under pressure with reduced oc-
cludin content demonstrated a 50% decrease in permeability to
70 kDa RITC-dextran compared with control siRNA-treated
cells (Fig. 4A). Because preliminary experiments demonstrated
TAMRA permeability was much higher than 70 kDa RITC
dextran, it was not possible to measure permeability over the
same time course as for the larger molecule. Therefore, per-
meability was measured starting 60 minutes after pressure
application because the cells appeared to reach equilibrium at
this time point. In contrast to the larger molecule, TAMRA
permeability increased 50% in occludin siRNA-treated cells
compared with control cells (Fig. 4B).
The use of occludin siRNA altered the cell’s response to the
application of a transmural pressure gradient. Figure 4C shows
a comparison of TAMRA and 70 kDa RITC-dextran permeability
before and after pressure application. Normally, the cells re-
sponded to the elevated pressure and increased permeability
with an adaptive response, reducing the permeability across
the RPE monolayer for both small and large molecules. This
adaptive response led to a final rate of permeability under
transmural pressure nearly equal to the nonpressure conditions
for the small molecule TAMRA, as seen in Figure 4C. However,
with occludin siRNA, the permeability to 467 Da TAMRA was
elevated 50% after the application of pressure, suggesting a
reduced adaptive response. Meanwhile, an adaptive response
was observed in the permeability to 70 kDa RITC-dextran after
pressure application in control and siRNA-treated cells (Figs.
4A, 4C). After pressure, there was twofold greater permeability
to 70 kDa RITC-dextran in control cells than in siRNA-treated
cells. These data demonstrate that the retinal pigment epithe-
lium differentially regulates permeability to 70 kDa dextran and
the smaller 467 Da TAMRA molecules and that occludin has
specific control of small molecule permeability.
Occludin siRNA Increases the Rate
of Cell Division
Changes in cell division or cell number could potentially ac-
count for molecule-specific changes in permeability. There-
fore, cell number, cell death, and rate of cell division were
assessed in control and occludin siRNA-treated cells. Immuno-
cytochemistry was performed with the Ki67 antibody to mark
entry into the cell cycle (Fig. 5A). Cells were counterstained
with Hoechst nuclear stain, and a ratio of Ki67 to Hoechst-
stained cells was determined. Occludin siRNA significantly
increased the number of Ki67-positive cells from 15% to 23% of
the total (Fig. 5C), suggesting occludin reduction increases the
number of cells undergoing active cell cycle. Reducing occlu-
din content 65% with occludin siRNA also increased tritiated
thymidine incorporation by 90% compared with controls (Fig.
5D), demonstrating increased DNA synthesis. This effect was
dependent on the content of occludin because a separate
siRNA to occludin (occludin siRNA 143664; Ambion) that re-
duced occludin content 38% increased tritiated thymidine in-
corporation 25% (data not shown). Together these data dem-
onstrate that occludin contributes to the control of cell cycle in
ARPE-19 cells.
Alterations in cell viability and cell death were examined to
account for the change in cell cycle entry. Cell viability after
occludin siRNA treatment was determined by flow cytometry
in ARPE-19 cells. No significant difference existed in total
number of viable or dead cells between control and occludin
siRNA treatments (Fig. 5E). In addition, ARPE-19 monolayers
were assessed for viability with calcein AM and cytotoxicity
with ethidium bromide staining. No significant differences in
monolayer cell viability or cell death were detected between
control and occludin siRNA-treated cells (Figs. 5F, 5G), sug-
gesting that cell viability was not compromised by the siRNA.
The DNA content of ARPE-19 monolayers was unchanged (Fig.
5H), but culture media DNA content was twofold greater in
occludin siRNA-treated cells (Fig. 5G), suggesting siRNA-
treated monolayers maintain cell numbers by releasing excess
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FIGURE 1. Junctional protein and mRNA content after occludin deple-
tion. ARPE-19 cells were transfected with negative control (CN) or
occludin-targeted siRNA (siRNA). Cells were harvested 4 days later, and
mRNA and protein content were analyzed. (A) RT-PCR quantification,
mean, and SE of the mean (SEM) of CN and siRNA-treated cells (n  6).
(B) Western blot analysis of ZO-1, occludin, and claudin-1. (C) Densi-
tometric quantification of Western blot, mean, and SEM (n  3). Of the
junctional components examined, only the tight junctional protein
occludin showed significant changes in mRNA and protein content.
Two-tailed t-test was performed to determine significance. **P  0.01;
***P  0.001.
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Permeability Is Independent of the Rate
of Cell Division
The increased rate of cell division in occludin siRNA-treated
cells could contribute to ARPE-19 paracellular permeability;
therefore, two cell cycle inhibitors were selected to block cell
division. Aphidicolin is a DNA polymerase I inhibitor that stops
cells in the early S phase of the cell cycle. Roscovitine is a
cyclin-dependant kinase inhibitor that stops cells in the early S
and mitotic phases of the cell cycle. Figure 6A shows the
relative amount of tritiated thymidine incorporation after 4
hours of treatment with 5 M aphidicolin, 10 M roscovitine,
or an equal volume of vehicle control DMSO. Occludin siRNA
increased thymidine incorporation by 70%, similar to previous
results (Figs. 5D, 6A). DNA synthesis was blocked by 90% with
5 M aphidicolin and 70% with 10 M roscovitine (Fig. 6A).
The TER measured across the cell monolayer was unaffected
by drug treatment, suggesting increased cell division did not
account for the reduced TER after occludin siRNA treatment
(Fig. 6B). Similarly, diffusive permeability to 70 kDa RITC-
dextran was unaffected by reductions in cell division rates (Fig.
6C). The increase in diffusive TAMRA permeability after occlu-
din siRNA treatment was not affected by aphidicolin (Fig. 6D)
or roscovitine (Fig. 6E) treatment. These data suggest that the
permeability changes resulted from reduced occludin content
at the junction and not from increased proliferation.
DISCUSSION
The major findings of this study were that occludin regulates
cell proliferation and paracellular permeability in ARPE-19 cells
under physiological hydrostatic pressure. Numerous experi-
mental models have examined the role of the tight junction
protein occludin in regulating paracellular permeability, dem-
onstrating a strong correlation between occludin content and
permeability characteristics13,14 and providing experimental
evidence for occludin in contributing to barrier properties.40,41
However, gene deletion experiments have found little evi-
dence of occludin in establishing barrier properties.27,28 Re-
cent evidence has pointed to a role for occludin in regulating
cell growth, including increased gastric mucus cell hyperplasia
after occludin knockout27,28 and reversion of the raf-trans-
formed phenotype by exogenous expression of occludin.29
Further, occludin directs TGFR1 to the tight junction, which
is required for TGF-induced epithelial-to-mesenchymal cell
transition.42 Here an siRNA to occludin was used in ARPE-19
cells to reduce occludin content by transient transfection to
examine the contribution of occludin to blood-retinal barrier
properties under conditions of a hydrostatic pressure gradient
and to examine the contribution of occludin depletion to
growth control. We report that occludin contributes to the
regulation of barrier properties under hydrostatic pressure and
also to the regulation of cell division.
The reduction in occludin protein content increased per-
meability to the small 467 Da TAMRA molecules but had no
effect on permeability to RITC-dextran molecules of 70 kDa
and 10 kDa under diffusive conditions. This is similar to find-
ings in MDCK II cells with constitutive ablation of occludin
protein.26 The application of occludin-blocking peptides in
various tissue culture models has also demonstrated increases
in small molecule permeability23,24 and in larger 3-kDa and
FIGURE 2. Occludin siRNA treatment did not inhibit ARPE-19 tight
junction formation. ARPE-19 cells were treated with control negative
and occludin-targeted siRNA (siRNA). Cells reached confluence 1 day
after treatment and were fixed on day 4. (A) Immunocytochemistry
was performed on ARPE-19 monolayers for tight junction proteins
occludin (green) and ZO-1 (red). Occludin content and localization at
the plasma membrane were reduced with occludin siRNA treatment,
while ZO-1 was unaffected. (B) Sections were cut perpendicularly to
the plane of the fixed cell monolayer and were examined by electron
microscopy. These images were of cells exposed to transmural 10 cm
H2O pressure before fixation. Nonpressurized cells were similar in
appearance (data not shown).
2572 Phillips et al. IOVS, June 2008, Vol. 49, No. 6
Downloaded from iovs.arvojournals.org on 07/01/2019
40-kDa dextran molecules in some studies.21,23 Surprisingly,
occludin-deficient mice do not display increased permeability
to mannitol in isolated intestinal epithelia despite a number of
phenotypic defects associated with tissues containing tight
junctions.27,28 The difference in this study and the knockout
mice may be attributed to cell context, as was demonstrated
with claudin gene depletion,43 or perhaps from a difference in
transient depletion compared with development with occludin
gene deletion. The present results examining permeability un-
der diffusive conditions agree with many of the previous stud-
ies demonstrating that blockade of occludin increases small
molecule and ion permeability with a modest 15% to 20%
change.
The effect of occludin depletion on tight junction perme-
ability has not been previously tested under physiological pres-
sure. The hydrostatic pressure present in physiological micro-
environments of cell and tissue barriers affects the net
movement of water and solutes across tissues. Previous studies
have demonstrated that the application of pressure results in
increased ZO-1 immunoreactivity at the cell border and a
subsequent sealing to water and solute permeability in endo-
thelial cells.33 The results of the present study are the first
demonstration of this adaptive sealing response in epithelial
cells. However, though control RPE cells also resisted an in-
crease in permeability of TAMRA after the application of trans-
mural pressure, the occludin-depleted cells demonstrated an
increase in permeability to TAMRA after pressure. These data
suggest that occludin is necessary for the cell’s adaptive re-
sponse to changes in pressure. Interestingly, occludin deple-
FIGURE 3. Diffusive paracellular permeability of ARPE-19 monolayers
is modestly affected by occludin siRNA treatment. Graphs display
permeability mean and SEM. (A) Paracellular permeability to 70 kDa
(n  20) and 10 kDa (n  10) RITC-dextran molecules was measured
over a 3.5-hour time course and the 467 Da TAMRA (n  15) over a
2-hour time course. (B) ARPE-19 monolayer TER was measured twice
per transwell filter and averaged (n  32). Two-tailed t-test was per-
formed to determine significance. *P  0.05; ***P  0.001.
FIGURE 4. Occludin dynamically regulates paracellular permeability
under hydrostatic pressure. (A). Ten centimers H2O transmural pres-
sure was applied to ARPE-19 monolayers at 0 minutes, and permeabil-
ity to 70 kDa was calculated over 5-minute time intervals for 2 hours
(CN, n  8; siRNA, n  7). Pressure application initially resulted in a
fourfold to sevenfold elevation of permeability to 70 kDa dextran,
followed by a reduction over the next 60 minutes. Statistical signifi-
cance was determined from 65 to 115 minutes by two-way ANOVA
(P  0.05) and two-tailed t-test performed on AUC values (P  0.01).
(B) ARPE-19 permeability to 467 Da TAMRA was measured starting 1
hour after pressure application, and statistical significance was deter-
mined over 65 to 145 minutes (ANOVA, P  0.05; AUC, P  0.05; CN,
n  6; siRNA, n  8). (C) Comparison of diffusive permeability (Fig.
3A) and average permeability under pressure (over the same timeframe
described) for 70 kDa dextran and TAMRA permeability. Statistical
significance was determined as stated (*P  0.05). Occludin siRNA
treatment increased permeability to TAMRA in diffusive and pressured
conditions but decreased permeability to 70kDa RITC-dextran com-
pared with control-treated cells under pressure, suggesting occludin
dynamically regulates permeability.
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tion in MDCK II cells altered the cell’s response to cholesterol
depletion.26 Together, these studies suggest a role for occludin
in signaling changes in barrier properties in response to exter-
nal signals.
In contrast to TAMRA, permeability to 70 kDa dextran was
reduced in occludin siRNA-treated cells after pressure applica-
tion when compared with controls, though both conditions
adapted to the elevated pressure. It is not clear what caused
this unexpected decrease in 70 kDa dextran paracellular per-
meability in occludin-siRNA treated cells, but one possibility is
that there were compensatory changes in the adherens junc-
tion after occludin depletion. Adherens junctions restrict large
molecule permeability in the absence of a functional tight
junction,44,45 but it is not clear why the reduction of occludin
would result in the strengthening of the adherens junction.
One possibility is that ZO-1 moves from the tight junction to
the basal adherens junction with the loss of occludin. The same
SH3-linked guanylate kinase domain of ZO-1 binds either oc-
cludin or the adherens junction protein -catenin.46 Increased
transcription of the adherens junction protein -catenin has
also been observed after the loss of occludin at the plasma
membrane.22 The results reported here suggest that TAMRA is
restricted by tight junctions alone and that 70 kDa dextran is
restricted by both tight junctions and adherens junctions, con-
sistent with the literature. However, other possibilities remain,
including altered endocytosis or phagocytosis affecting trans-
cellular permeability after occludin siRNA treatment in the
ARPE-19 cells.
A surprising outcome of these studies is that occludin con-
tributes to growth control in ARPE-19 cells. Alterations in
growth were examined as a potential route for increased per-
meability, but blockade of the cell cycle demonstrated that the
change in cell division did not cause the increased TAMRA
permeability after occludin depletion. Recent studies have im-
plicated tight junction proteins in regulating rates of cell pro-
liferation.22,29,47 The tight junction protein ZO-1 has been
shown to regulate cell division through binding and sequester-
ing the transcription factor ZONAB at the cell border.47 Addi-
tionally, exogenous expression of occludin was sufficient to
reverse a raf-transformed phenotype.29 The present results
support these previous findings and demonstrate for the first














































































































































































FIGURE 5. ARPE-19 cell division rates increase after occludin siRNA
treatment. ARPE-19 cells were treated with control (CN) and occludin-
targeted siRNA (siRNA). Graphs display mean and SEM values. (A)
Immunocytochemistry was performed with Hoechst nuclear stain
(gray cells) and Ki67 antibody (white cells) on confluent ARPE-19
monolayers. Ki67 is a nuclear protein expressed only in actively divid-
ing cells during the G1, S, G2, and mitotic cell cycle phases. (B) Cell
density was quantified by counting the number of Hoechst-stained
cells per field and was unchanged between treatment conditions (n 
3). (C) The percentage of cells that stained positive for Ki67 increased
50% with occludin siRNA treatment compared with the control scram-
bled treatment (n  3). (D) 3H-thymidine incorporation over 2 hours
increased 90% in occludin siRNA-treated cells compared with control
scrambled-treated cells (n  12). (E) Flow cytometry was performed
on resuspended ARPE-19 monolayers (CN, n  7; siRNA, n  8). Cells
were labeled with Annexin V-PE, which binds to the phosphatidylser-
ine exposed on the cell membrane surface during early apoptosis, and
the vital cell dye 7-AAD, which is excluded from living cells. Quadrant
analysis was performed, and cells stained positively for Annexin V or
7-AAD were designated as dead, whereas unstained cells were desig-
nated as live. ARPE-19 monolayers were incubated with (F) calcein,
which is taken up by living cells, and (G) ethidium bromide, which is
excluded from living cells (CN, n  9; siRNA, n  8; alcohol, n  4).
A positive cell death control was treated with 70% ethanol for 30
minutes. Relative incorporation was measured with a spectrophotom-
eter. No significant difference in cell viability existed between siRNA-
treated and control APRE-19 cells. DNA content was measured in
APRE-19 (H) cell monolayers and (I) cell culture media on cells from
day 3 to day 4 after siRNA treatments (n  6). DNA content did not
change in the cell monolayer but significantly increased twofold in cell
media from control scrambled-treated to occludin siRNA-treated cells.
These data demonstrate occludin siRNA treatment increased cell divi-
sion rates without changing cell number or viability within ARPE-19
monolayers compared with control. Excess cells are released into the
media. Two-tailed t-test or ANOVA (if more than two conditions) was
performed to determine significance (*P  0.05; ***P  0.001).
2574 Phillips et al. IOVS, June 2008, Vol. 49, No. 6
Downloaded from iovs.arvojournals.org on 07/01/2019
Thus, this study demonstrated for the first time that RPE
cells have an adaptive response like that of endothelial cells
and that occludin contributes to the cell’s adaptive response
after pressure application. Further, occludin has a separate
function in controlling cell division. These studies support a
role for occludin in the regulation of barrier properties, partic-
ularly in response to changes in environmental stressors, and
demonstrate a novel role of occludin in the regulation of cell
growth.
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